While these studies show a correlation between MMP-2 and breast cancer aggressiveness, preclinical animal models have also defined causal roles for MMP-2 in promoting invasion and metastasis via ECM degradation and angiogenesis [29,30]. Here, MMP2 is linked to breast carcinoma.